StockData
Vivani Medical, Inc. logo

Vivani Medical, Inc. (VANI) stock

VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.05+0.03 (+2.94%)

Close on Nov 17, 2026Market cap $94.71MP/E –Yield –

Vivani Medical r&d expenses

Research and development expenses are spending on new products and technology.

Vivani Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $18.00M, up 2.9% year over year. For fiscal 2025 it was $18.13M, up 15.1% from the year before. Over ten years it grew 19.6% a year on average. The highest annual figure on record is $18.13M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$18.13M+15.1%
FY2024Dec 31, 2024$15.75M-7.2%
FY2023Dec 31, 2023$16.97M+19.8%
FY2022Dec 31, 2022$14.17M+28.8%
FY2021Dec 31, 2021$11.00M+127.5%
FY2020Dec 31, 2020$4.84M-63.2%
FY2019Dec 31, 2019$13.14M+31.4%
FY2018Dec 31, 2018$10.01M+26.8%
FY2017Dec 31, 2017$7.89M+47.6%
FY2016Dec 31, 2016$5.35M+76.1%
FY2015Dec 31, 2015$3.04M-39.8%
FY2014Dec 31, 2014$5.04M+55.2%
FY2013Dec 31, 2013$3.25M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.46M-6.4%
Q1 FY2026Mar 31, 2026$4.39M+4.1%
Q4 FY2025Dec 31, 2025$4.63M+7.6%
Q3 FY2025Sep 30, 2025$4.52M+7.5%
Q2 FY2025Jun 30, 2025$4.76M+35.5%
Q1 FY2025Mar 31, 2025$4.22M+13.2%
Q4 FY2024Dec 31, 2024$4.30M-8.6%
Q3 FY2024Sep 30, 2024$4.20M-5.4%
Q2 FY2024Jun 30, 2024$3.51M-9.1%
Q1 FY2024Mar 31, 2024$3.73M-5.8%
Q4 FY2023Dec 31, 2023$4.71M+6.3%
Q3 FY2023Sep 30, 2023$4.44M+15.1%
Q2 FY2023Jun 30, 2023$3.86M+20.6%
Q1 FY2023Mar 31, 2023$3.96M+47.6%
Q4 FY2022Dec 31, 2022$4.43M+48.8%
Q3 FY2022Sep 30, 2022$3.86M+34.6%
Q2 FY2022Jun 30, 2022$3.20M+360.9%
Q1 FY2022Mar 31, 2022$2.68M+702.1%
Q4 FY2021Dec 31, 2021$2.98M+757.3%
Q3 FY2021Sep 30, 2021$2.87M+928.0%
Q2 FY2021Jun 30, 2021$695.00K+115.2%
Q1 FY2021Mar 31, 2021$334.00K-91.4%
Q4 FY2020Dec 31, 2020$347.00K-91.6%
Q3 FY2020Sep 30, 2020$279.00K-91.7%
Q2 FY2020Jun 30, 2020$323.00K-90.6%
Q1 FY2020Mar 31, 2020$3.89M+78.1%
Q4 FY2019Dec 31, 2019$4.15M+70.0%
Q3 FY2019Sep 30, 2019$3.38M+26.5%
Q2 FY2019Jun 30, 2019$3.44M+41.9%
Q1 FY2019Mar 31, 2019$2.18M-11.8%
Q4 FY2018Dec 31, 2018$2.44M+7.4%
Q3 FY2018Sep 30, 2018$2.67M+46.3%
Q2 FY2018Jun 30, 2018$2.42M+24.3%
Q1 FY2018Mar 31, 2018$2.47M+33.9%
Q4 FY2017Dec 31, 2017$2.27M+9.1%
Q3 FY2017Sep 30, 2017$1.83M+15.0%
Q2 FY2017Jun 30, 2017$1.95M–
Q1 FY2017Mar 31, 2017$1.85M–
Q4 FY2016Dec 31, 2016$2.08M–
Q3 FY2016Sep 30, 2016$1.59M–

More Vivani Medical figures

See a number that looks wrong?